BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32169871)

  • 1. Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination.
    Abdulrahman Z; de Miranda N; van Esch EMG; de Vos van Steenwijk PJ; Nijman HW; J P Welters M; van Poelgeest MIE; van der Burg SH
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pre-existing coordinated inflammatory microenvironment is associated with complete response of vulvar high-grade squamous intraepithelial lesions to different forms of immunotherapy.
    Abdulrahman Z; de Miranda NFCC; Hellebrekers BWJ; de Vos van Steenwijk PJ; van Esch EMG; van der Burg SH; van Poelgeest MIE
    Int J Cancer; 2020 Nov; 147(10):2914-2923. PubMed ID: 32574376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses.
    Welters MJ; Kenter GG; de Vos van Steenwijk PJ; Löwik MJ; Berends-van der Meer DM; Essahsah F; Stynenbosch LF; Vloon AP; Ramwadhdoebe TH; Piersma SJ; van der Hulst JM; Valentijn AR; Fathers LM; Drijfhout JW; Franken KL; Oostendorp J; Fleuren GJ; Melief CJ; van der Burg SH
    Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11895-9. PubMed ID: 20547850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response.
    van Poelgeest MI; Welters MJ; Vermeij R; Stynenbosch LF; Loof NM; Berends-van der Meer DM; Löwik MJ; Hamming IL; van Esch EM; Hellebrekers BW; van Beurden M; Schreuder HW; Kagie MJ; Trimbos JB; Fathers LM; Daemen T; Hollema H; Valentijn AR; Oostendorp J; Oude Elberink JH; Fleuren GJ; Bosse T; Kenter GG; Stijnen T; Nijman HW; Melief CJ; van der Burg SH
    Clin Cancer Res; 2016 May; 22(10):2342-50. PubMed ID: 26813357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions.
    Abdulrahman Z; Hendriks N; J Kruse A; Somarakis A; J M van de Sande A; J van Beekhuizen H; M J Piek J; de Miranda NFCC; Kooreman LFS; F M Slangen B; van der Burg SH; de Vos van Steenwijk PJ; van Esch EMG
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36323430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.
    Davidson EJ; Boswell CM; Sehr P; Pawlita M; Tomlinson AE; McVey RJ; Dobson J; Roberts JS; Hickling J; Kitchener HC; Stern PL
    Cancer Res; 2003 Sep; 63(18):6032-41. PubMed ID: 14522932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
    Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.
    Kenter GG; Welters MJ; Valentijn AR; Lowik MJ; Berends-van der Meer DM; Vloon AP; Essahsah F; Fathers LM; Offringa R; Drijfhout JW; Wafelman AR; Oostendorp J; Fleuren GJ; van der Burg SH; Melief CJ
    N Engl J Med; 2009 Nov; 361(19):1838-47. PubMed ID: 19890126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
    Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
    Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial.
    Bakker NAM; Rotman J; van Beurden M; Zijlmans HJM; van Ruiten M; Samuels S; Nuijen B; Beijnen J; De Visser K; Haanen J; Schumacher T; de Gruijl TD; Jordanova ES; Kenter GG; van den Berg JH; van Trommel NE
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34341131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune microenvironment in vulvar (pre)cancer: review of literature and implications for immunotherapy.
    Abdulrahman Z; Kortekaas KE; De Vos Van Steenwijk PJ; Van Der Burg SH; Van Poelgeest MI
    Expert Opin Biol Ther; 2018 Dec; 18(12):1223-1233. PubMed ID: 30373410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of coinhibitory receptors on T cells in the microenvironment of usual vulvar intraepithelial neoplasia is related to proinflammatory effector T cells and an increased recurrence-free survival.
    van Esch EM; van Poelgeest MI; Kouwenberg S; Osse EM; Trimbos JB; Fleuren GJ; Jordanova ES; van der Burg SH
    Int J Cancer; 2015 Feb; 136(4):E95-106. PubMed ID: 25220367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status.
    Kortekaas KE; Santegoets SJ; Abdulrahman Z; van Ham VJ; van der Tol M; Ehsan I; van Doorn HC; Bosse T; van Poelgeest MIE; van der Burg SH
    J Immunother Cancer; 2019 Sep; 7(1):236. PubMed ID: 31481117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraepithelial macrophage infiltration is related to a high number of regulatory T cells and promotes a progressive course of HPV-induced vulvar neoplasia.
    van Esch EM; van Poelgeest MI; Trimbos JB; Fleuren GJ; Jordanova ES; van der Burg SH
    Int J Cancer; 2015 Feb; 136(4):E85-94. PubMed ID: 25220265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery followed by persistence of high-grade squamous intraepithelial lesions is associated with the induction of a dysfunctional HPV16-specific T-cell response.
    de Vos van Steenwijk PJ; Piersma SJ; Welters MJ; van der Hulst JM; Fleuren G; Hellebrekers BW; Kenter GG; van der Burg SH
    Clin Cancer Res; 2008 Nov; 14(22):7188-95. PubMed ID: 19010835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8
    Çuburu N; Khan S; Thompson CD; Kim R; Vellinga J; Zahn R; Lowy DR; Scheper G; Schiller JT
    Int J Cancer; 2018 Apr; 142(7):1467-1479. PubMed ID: 29159802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.
    Jindra C; Huber B; Shafti-Keramat S; Wolschek M; Ferko B; Muster T; Brandt S; Kirnbauer R
    PLoS One; 2015; 10(9):e0138722. PubMed ID: 26381401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions.
    Maldonado L; Teague JE; Morrow MP; Jotova I; Wu TC; Wang C; Desmarais C; Boyer JD; Tycko B; Robins HS; Clark RA; Trimble CL
    Sci Transl Med; 2014 Jan; 6(221):221ra13. PubMed ID: 24477000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy.
    Kortekaas KE; Santegoets SJ; Tas L; Ehsan I; Charoentong P; van Doorn HC; van Poelgeest MIE; Mustafa DAM; van der Burg SH
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34716208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions.
    de Vos van Steenwijk PJ; Ramwadhdoebe TH; Löwik MJ; van der Minne CE; Berends-van der Meer DM; Fathers LM; Valentijn AR; Oostendorp J; Fleuren GJ; Hellebrekers BW; Welters MJ; van Poelgeest MI; Melief CJ; Kenter GG; van der Burg SH
    Cancer Immunol Immunother; 2012 Sep; 61(9):1485-92. PubMed ID: 22684521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.